Brian McNamara, Haleon CEO
GlaxoSmithKline tees up ‘Haleon’ brand name for consumer healthcare spinoff
From more than 2000 potential candidates, GlaxoSmithKline chose Haleon as the name of its consumer healthcare company spinoff. The newly announced
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
